Table 1. Patients and classification of rejectiona

Age/GenderMLVDAIATAVCICTCVGraft LossPresent Graft Function
(Weeks from Transplantation)
a ND, patient data not available; +, patient death with functioning graft; MLVD, median lymphovascular density per middle-power microscopic field; AI, AT, AV and CI, CT and CV, grading of rejection in the Banff nomenclature.
Biopsies with nodular infiltrates
    HG 35 m41.6100220571 (Crea 2.2)
    HJ 51 m37.0322210208 (Crea 1.2)
    SH 49 m23.1210211ND
    FA 26 f24.8210322590
    IZ 34 m23.0100222620 (Crea 1.4)
    PK 45 m22.9122222379
    TJ 42 f21.0220210670 (Crea 1.0)
    BF 67 f19.5000210ND
    NA 37 m19.0120332190
    ZE 57 f18.8220221590
    NH 34 f16.81102105
    WH 52 f16.2230211ND
    AL 68 m15.7000221485
    LB 49 m14.6101221ND
    DE 48 f14.0210210ND
    KE 39 m14.0130330105
    DD 53 f14.0332220120 (Crea 0.75)
    AA 37 f13.421022135 (Crea 0.75)
    AV 24 m12.6220210300 (Crea 2.46)
    WT 19 m11.8110212149
    SM 50 m9.6221221ND
    AA 60 f8.5333222ND
    WE 57 f8.1112210640
    VV 56 m8.033310084 (Crea 3.05)
    KO 49 m7.9120212140+
    PT 46 f7.5331100ND
    RL 47 f7.300110112
    MM 60 m6.8100211685 (Crea 1.7)
    GC 34 f6.2222100230 (Crea 4.1)
    NC 33 m6.0330100712 (Crea 4.7)
    SH 60 m6.0220110ND
    SE 49 m6.0230101352 (Crea 1.46)
    MS 37 f4.3222100140+
    WG 43 f4.333111065 (Crea 2.0)
    AA 43 m3.7331210ND
Biopsies without nodular infiltrates
    SM 60 f3.033200035 (Crea ND)
    JP 29 m2.533100114 (Crea 1.63)
    SM 49 f2.033200135 (Crea 2.0)
    KM 16 f2.2220010350 (Crea 2.46)
    RF 64 m2.1100000346 (Crea 2.2)
    SS 33 f1.8000002130+
    SH 60 m1.6320000ND
    KE 28 m1.0001100190
    PP 50 m0.8111002510 (Crea 3.5)
    LG 50 f0.8221001ND
    SJ 45 m0.1211111ND
    AI 50 f0.1221001ND